Calycosin Inhibits Pulmonary Fibrosis Through the Regulation of miR-375/YAP1 Signaling Pathway
Hui Ji,Linna Guo,Yongtao Li,Yang Jiang,Yuchun Wang,Haifeng Jin
DOI: https://doi.org/10.1007/s43450-022-00326-x
2022-10-19
Brazilian Journal of Pharmacognsosy
Abstract:Pulmonary fibrosis is a chronic lung disease characterized by epithelial-mesenchymal transition. Calycosin, the main active flavonoid isolated from roots of Astragalus species, has anti-fibrotic properties. Human normal lung epithelial cell line (BEAS-2B) was treated with transforming growth factor beta1 to induce pulmonary fibrosis in vitro . The expression of epithelial-mesenchymal transition-related genes, microRNA (miR)-375 and YAP1, was measured using reverse transcription quantitative polymerase chain reaction and western blotting. The effect of miR-375 and YAP1 on epithelial-mesenchymal transition in pulmonary fibrosis was detected by transfecting miR-375 mimic or YAP1-plasmid into BEAS-2B cells. In addition, intervention of calycosin with an miR-375 inhibitor on pulmonary fibrosis clarified the relationship between this natural product and the miR-375/YAP1 signaling pathway in pulmonary fibrosis. The study found that calycosin did not have a toxic effect on BEAS-2B cells, whereas at high concentrations, this tested compound significantly inhibited the viability of transforming growth factor-beta1 (TGF-β1)–induced BEAS-2B cells. Epithelial-mesenchymal transition was activated, miR-375 expression was decreased, and YAP1 was increased in pulmonary fibrotic cells. However, calycosin treatment inhibited epithelial-mesenchymal transition, increased the expression level of miR-375, and decreased the level of YAP1. These results suggest that upregulation of miR-375 can inhibit the occurrence of epithelial-mesenchymal transition by inhibiting YAP1, whereas calycosin can increase the expression of miR-375 to inhibit TGF-β1–induced epithelial-mesenchymal transition and alleviate pulmonary fibrosis. miR-375 inhibited TGF-β1–induced epithelial-mesenchymal transition by inhibiting YAP1 expression in BEAS-2B cells, whereas calycosin inhibited pulmonary fibrosis by regulating the miR-375/YAP1 signaling pathway. Graphical
What problem does this paper attempt to address?